untitled design

With investments of 605 million euros, the pharmaceutical companies are offsetting the claw back

LAST UPDATE: 13:09

Of Tasos Dasopoulos

With investments of a total budget of 604,849,335.12 euros submitted in the action: “Clawback System Reforms & Offsetting with Research & Investment Expenditures”, the beneficiary pharmaceutical companies offset the return via claw back

This action has a budget of 250,000,000 euros, is funded by the Fund for Recovery and Resilience and its Implementing Agency is the General Secretariat for Research and Innovation of the Ministry of Development and Investment. the state with investments in percentages on R&D expenditure and investment plan development costs of products or services or production lines.

By April 28, 2022, the deadline for submission of applications, 65 aid applications were submitted to the State Aid Information System (PSE), from 40 potential beneficiaries with a total budget of approximately 605 million euros with a requested grant of 292.3 million euros.

The 50 requests concern investments in Research and Development (R&D). The total budget of these amounts to 403,486,170.77 euros and the requested grant to 213,607,973.94 euros. The remaining 15 requests are related to the support of productive investment projects. Their total budget is 201,363,164.35 euros and the requested grant is 78,686,733.07 euros.

It is noted that, based on the invitation, the beneficiaries had the opportunity to submit up to three applications for support of R&D projects and up to three investment projects, respectively.

The Deputy Minister of Finance, Mr. Theodoros Skylakakis, responsible for the implementation of the National Plan for Recovery and Sustainability “Greece 2.0”, stated: of “Greece 2.0” for the clawback, went so far as to exceed the budget. The significant investments that will be implemented, within the framework of the action, by the pharmaceutical industry, are expected to create at least 2,000 new highly specialized jobs “.

The Minister of Development and Investment, Mr. Adonis Georgiadis, pointed out: “From the first day we introduced the pharmaceutical clawback, it seemed that it would be a very powerful development tool for the Greek economy. However, its inclusion in the Recovery Fund gave it a completely different The results submitted are the obvious proposals submitted.Investment projects worth 605 million euros by large companies that will transform Greece into one of the most powerful countries in the world of medicine, all from the implementation of a smart idea in cooperation between the Ministries “Finance, Development and Health. We welcome these investment plans and are committed to working with investors to implement all these important investments quickly and efficiently for the good of the Greek people.”

Source: Capital

You may also like

Get the latest

Stay Informed: Get the Latest Updates and Insights

 

Most popular